resources
Is Your EMS Partner Actually Built for Medical? 7 Things to Check Before You Commit
/)
/)
Published on 16th October 2026
Medical device electronics manufacturing has no margin for ambiguity. A solder void on a PCBA inside a patient monitor, an undocumented component substitution, or a poorly managed handoff between suppliers can trigger a regulatory audit, a product recall, or a patient safety event.
The journey from bare PCB to a fully integrated, tested, compliant device involves multiple disciplines, multiple processes, and multiple points where quality is either built in or quietly lost. Choosing the right contract manufacturing partner is not a procurement decision. It is a programme risk decision.
Here are seven things every medical device OEM should demand before committing a programme to an electronics manufacturing services (EMS) provider.
ISO 13485:2016 requires that production processes be validated, not merely documented. Before a single production board runs, the reflow profile, stencil aperture geometry, paste volume, and placement coordinates must be locked. Any subsequent change, even a minor thermal adjustment, requires documented review and re-validation.
Ask your EMS partner to show IQ/OQ/PQ records for their SMT line. A certificate on the wall is not the same as a validated, controlled process.
Medical electronics require a layered inspection sequence. IPC-A-610 Class 3 is the applicable standard for medical devices, and it demands more than visual checks. A capable partner should run:
Solder paste inspection (SPI) after stencil printing
Automated optical inspection (AOI) post-reflow for placement and solder fillet quality
X-ray inspection (AXI) for hidden joints under BGAs and bottom-terminated packages
In-circuit or flying probe testing for electrical continuity against the netlist
Functional testing before the board progresses to integration
Each result must be recorded in the Device History Record. An inspection that is not documented has not, in regulatory terms, occurred.
Traceability is a regulatory requirement, not a quality metric. Every active and passive component placed on a PCBA must be traceable by lot and date code. Every reflow profile, inspection result, test outcome, and operator ID must be logged against each unit's serial number.
A manufacturer without a functioning Manufacturing Execution System (MES) or equivalent validated documentation control is not equipped for regulated medical production.
The most common source of quality failures in medical device programmes is not the SMT line. It is the handoff between suppliers. When PCBA production, enclosure moulding, cable harness assembly, and box build integration are split across multiple vendors, every transition is a point where documentation can be incomplete, dimensional tolerances can conflict, and accountability for a defect becomes contested.
A manufacturing partner that controls injection moulding, SMT assembly, and box build integration within a single ISO 13485-certified quality management system eliminates those handoff risks. One QMS, one audit relationship, one accountable party.
Component lead times for medical-grade electronics regularly exceed 20 weeks. When a part becomes constrained, the pressure to qualify an alternative is real. So is the risk. In a regulated programme, any change to the approved component list requires a documented change control process. A pin-compatible alternative from a different manufacturer may alter dielectric properties or EMC performance in ways that affect clinical function.
A capable EMS partner manages this proactively: strategic inventory buffers, qualified alternate sourcing, and a change notification protocol that keeps the OEM in the loop before any substitution is made. Partners that substitute without notification do not just create quality risk. They create regulatory exposure.
ISO 13485 certification is the entry requirement, not the differentiator. What matters is whether the quality system functions in practice. Look for:
Controlled work instructions available at every production station
Documented operator qualification and training records
A functioning CAPA system with closed-loop evidence
Audit-ready DHRs for every unit produced
A manufacturer with no CAPA records is not a well-controlled manufacturer. It is one that is not finding its problems.
The 2026 FDA QMSR transition makes this point sharper: supplier quality agreements and audit reports are now directly visible during FDA inspections. Any gap in a contract manufacturer's quality system appears on the OEM's record.
The most expensive manufacturing problems are the ones that cannot be fixed without a design change. Design for Manufacturability (DfM) and Design for Testability (DfT) reviews conducted before design freeze prevent re-validation events and compress the NPI cycle.
A manufacturing partner that engages at the design stage, not just the production stage, is a different category of supplier. It is the difference between a vendor executing a drawing and an engineering partner protecting the programme.
Reliable medical device manufacturing is the result of every process, from the first solder paste deposit to the final system-level functional test, performed within a quality management system that treats documentation, traceability, and change control as production requirements.
The OEMs that experience the fewest regulatory surprises are those that treat their contract manufacturer's quality system as an extension of their own. Under the current QMSR framework, it is.
FVG supports medical device OEMs across the full manufacturing scope, from precision injection moulding and SMT assembly through to box build integration and functional test, within an ISO 13485-certified quality management system. To discuss a specific programme requirement, contact the FVG medical device manufacturing team.